BR100 Decreased By (-0.97%)
BR30 Decreased By (-1.55%)
KSE100 Decreased By (-0.89%)
KSE30 Decreased By (-0.94%)
AGHA 7.54 Decreased By ▼ -0.06 (-0.79%)
BECO 5.15 Decreased By ▼ -0.02 (-0.39%)
BML 57.92 Decreased By ▼ -0.60 (-1.03%)
BOP 33.35 Decreased By ▼ -0.60 (-1.77%)
CNERGY 10.76 Decreased By ▼ -0.19 (-1.74%)
CSIL 5.50 Decreased By ▼ -0.01 (-0.18%)
FCCL 54.68 Decreased By ▼ -1.17 (-2.09%)
FFL 16.07 Decreased By ▼ -0.14 (-0.86%)
FNEL 1.20 Decreased By ▼ -0.01 (-0.83%)
KEL 7.29 Decreased By ▼ -0.10 (-1.35%)
KOSM 5.97 Decreased By ▼ -0.08 (-1.32%)
LOTCHEM 27.32 Decreased By ▼ -0.38 (-1.37%)
MLCF 95.67 Decreased By ▼ -1.24 (-1.28%)
NBP 202.60 Decreased By ▼ -4.86 (-2.34%)
NCPL 56.31 Decreased By ▼ -0.65 (-1.14%)
NPL 66.25 Decreased By ▼ -1.05 (-1.56%)
OGDC 317.05 Decreased By ▼ -3.95 (-1.23%)
PACE 10.40 Decreased By ▼ -0.15 (-1.42%)
PAEL 42.34 Decreased By ▼ -0.85 (-1.97%)
PIBTL 16.77 Increased By ▲ 0.04 (0.24%)
PPL 218.15 Decreased By ▼ -4.69 (-2.1%)
PRL 57.37 Decreased By ▼ -1.78 (-3.01%)
PTC 70.58 Increased By ▲ 0.58 (0.83%)
SSGC 25.57 Decreased By ▼ -0.39 (-1.5%)
TBL 9.72 No Change ▼ 0.00 (0%)
TELE 8.32 Decreased By ▼ -0.24 (-2.8%)
TPL 19.67 Decreased By ▼ -0.15 (-0.76%)
TPLP 12.79 Increased By ▲ 0.03 (0.24%)
TREET 23.27 Increased By ▲ 0.45 (1.97%)
TRG 61.00 Increased By ▲ 0.61 (1.01%)
Topic

Novavax

Australia's CSL unable to simultaneously make Novavax, AstraZeneca vaccines

Australia's CSL unable to simultaneously make Novavax, AstraZeneca vaccines

Published 20 May, 2021 06:11pm
  • Australian biotech CSL is already under contract to locally make 50 million doses of the AstraZeneca vaccine, and is currently churning out more than a million doses a week.
  • Australia is relying on deliveries from Pfizer after restricting the use of AstraZeneca's shot in April in people below 50 years due to rare blood-clotting cases.
South Korea signs with Pfizer for additional 40mn COVID-19 vaccine doses

South Korea signs with Pfizer for additional 40mn COVID-19 vaccine doses

Published 24 Apr, 2021 05:58pm
  • It added that it had secured a total 192 million doses of vaccines, including those from Moderna Inc, AstraZeneca PLC, Johnson & Johnson's and Novavax.
  • "The government has acquired COVID-19 vaccines large enough to vaccinate approximately 100 million people...(which) is double the entire population of South Korea," Health Minister Kwon Deok-cheol told a briefing.
Indian shares rebound

Indian shares rebound

Published 14 Apr, 2021 03:21am
BENGALURU: Indian shares ended more than 1% higher on Tuesday after the government moved to fast-track approvals for...
Novavax vaccine 96% effective against original coronavirus, 86% vs British variant in UK trial

Novavax vaccine 96% effective against original coronavirus, 86% vs British variant in UK trial

Updated 12 Mar, 2021 04:07pm
  • There were no cases of severe illness or deaths among those who got the vaccine, the company said.
  • The vaccine was 86% effective in protecting against the more contagious virus variant first discovered and now prevalent in the United Kingdom, for a combined 90% effectiveness rate overall based on data from infections of both versions of the coronavirus.
Rich nations stockpiling a billion more COVID-19 vaccine shots than needed: Report

Rich nations stockpiling a billion more COVID-19 vaccine shots than needed: Report

Updated 19 Feb, 2021 02:55pm
  • In an analysis of current supply deals for COVID-19 vaccines, the ONE Campaign said wealthy countries, such as the United States and Britain, should share the excess doses to “supercharge” a fully global response to the pandemic.
  • On Thursday, the World Health Organization urged nations with vaccines not to share them unilaterally, but to donate them to the global COVAX scheme to ensure fairness.
EU close to vaccine supply deal with Novavax

EU close to vaccine supply deal with Novavax

Published 11 Feb, 2021 08:29pm
  • "Talks with Novavax have intensified and we aim to agree the contract this week or next," one EU official said.
  • Novavax said negotiations were ongoing. A spokesman for the EU Commission declined to comment on the talks.
Loading...